Bristol/ImClone Erbitux Launched At $600 Per Vial; $2,400 For Initial Dose

Bristol-Myers Squibb/Imclone's oncologic Erbitux launched Feb. 25 at an average wholesale price of $600 per 100 mg of cetuximab

More from Archive

More from Pink Sheet